Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma

Completed · Phase 2 · Has a placebo group

Conditions studied: Lipoma

In brief

The purpose of this study is to determine whether collagenase is effective in reducing the surface area of a subcutaneous benign lipoma.

Key facts

Study ID
NCT02249052
Run by
Gerut, Zachary, M.D.
People needed
19
Starts
2014-08-01
Expected to finish
2016-06-01
Last updated by the study team
2017-02-23

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.